A Wee1 kinase inhibitor increased cytotoxicity of oncolytic adenoviruses in p53-deficient cells

被引：0
|
作者：
Morinaga, T. [1 ]
Thao, N. T. [1 ,2 ]
Boya, Z. [1 ,2 ]
Tagawa, M. [1 ,2 ]
机构：
[1] Chiba Canc Ctr, Res Inst, Div Pathol & Cell Therapy, Chiba, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Biol & Oncol, Chiba, Japan
来源：
MOLECULAR BIOLOGY OF THE CELL | 2018年 / 29卷 / 26期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P1329
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] A Wee1 kinase inhibitor enhances replication and infectivity of oncolytic adenoviruses in p53-deficient cells
    Morinaga, Takao
    Thi Thanh Thao Nguyen
    Zhong, Boya
    Kubo, Shuji
    Sekine, Ikuo
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    Tagawa, Masatoshi
    CANCER SCIENCE, 2018, 109 : 253 - 253
  • [2] Multiple Defects Sensitize p53-Deficient Head and Neck Cancer Cells to the WEE1 Kinase Inhibition
    Diab, Ahmed
    Kao, Michael
    Kehrli, Keffy
    Kim, Hee Yeon
    Sidorova, Julia
    Mendez, Eduardo
    MOLECULAR CANCER RESEARCH, 2019, 17 (05) : 1115 - 1128
  • [3] Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells
    Garijo, Raquel
    Hernandez-Alonso, Pablo
    Rivas, Carmen
    Diallo, Jean-Simon
    Sanjuan, Rafael
    PLOS ONE, 2014, 9 (07):
  • [4] WEE1 kinase inhibition enhances PI3K inhibitor response in p53 deficient gliomas
    Wu, Shaofang
    Zheng, Siyuan
    Wang, Shuzhen
    Yung, W. K. Alfred
    Koul, Dimpy
    CANCER RESEARCH, 2015, 75
  • [5] Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents
    Hirai, Hiroshi
    Iwasawa, Yoshikazu
    Okada, Megumu
    Arai, Tsuyoshi
    Nishibata, Toshihide
    Kobayashi, Makiko
    Kimura, Toshifumi
    Kaneko, Naoki
    Ohtani, Junko
    Yamanaka, Kazunori
    Itadani, Hiraku
    Takahashi-Suzuki, Ikuko
    Fukasawa, Kazuhiro
    Oki, Hiroko
    Nambu, Tadahiro
    Jiang, Jian
    Sakai, Takumi
    Arakawa, Hiroharu
    Sakamoto, Toshihiro
    Sagara, Takeshi
    Yoshizumi, Takashi
    Mizuarai, Shinji
    Kotani, Hidehito
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (11) : 2992 - 3000
  • [6] MK-1775, a Potent Wee1 Inhibitor, Synergizes with Gemcitabine to Achieve Tumor Regressions, Selectively in p53-Deficient Pancreatic Cancer Xenografts
    Rajeshkumar, N. V.
    De Oliveira, Elizabeth
    Ottenhof, Niki
    Watters, James
    Brooks, David
    Demuth, Tim
    Shumway, Stuart D.
    Mizuarai, Shinji
    Hirai, Hiroshi
    Maitra, Anirban
    Hidalgo, Manuel
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2799 - 2806
  • [7] WEE1 kinase inhibitor shows promise
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (10) : 593 - 593
  • [8] WEE1 kinase inhibitor shows promise
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2019, 16 : 593 - 593
  • [9] MK-1775, a Novel Wee1 Kinase Inhibitor, Radiosensitizes p53-Defective Human Tumor Cells
    Bridges, Kathleen A.
    Hirai, Hiroshi
    Buser, Carolyn A.
    Brooks, Colin
    Liu, Huifeng
    Buchholz, Thomas A.
    Molkentine, Jessica M.
    Mason, Kathryn A.
    Meyn, Raymond E.
    CLINICAL CANCER RESEARCH, 2011, 17 (17) : 5638 - 5648
  • [10] Cooperative in vivo cytotoxicity of ionizing radiation and the protein kinase C-inhibitor PKC412 in p53-deficient, radioresistant tumor cells
    Zaugg, K
    Resch, H
    Hegyi, I
    Glanzmann, C
    Fabbro, D
    Bodis, S
    Pruschy, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S181 - S181
12345